Adapting a PTSD treatment for people using multiple substances
Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations
This study is testing a new version of a therapy program designed to help people with PTSD who are also using methadone and other substances, making it easier for them to access and benefit from the treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10590166 on NIH RePORTER |
What this research studies
This research aims to modify an existing PTSD intervention specifically for individuals in a methadone maintenance treatment program who are also dealing with polysubstance use, particularly involving opioids and stimulants. The project will adapt the Skills Training in Affective and Interpersonal Regulation with Narrative Therapy (STAIR-NT) to better suit the needs of this population, which often has complex histories of trauma and mental health issues. The approach includes a condensed treatment schedule to improve accessibility and effectiveness for patients. The research will assess the feasibility and acceptability of this adapted intervention through pilot testing and a small-scale randomized control trial.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals receiving treatment for opioid use disorder who also engage in polysubstance use, particularly those with a history of trauma.
Not a fit: Patients who do not have a history of polysubstance use or those not receiving treatment for opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a tailored treatment option that improves mental health outcomes for individuals struggling with both PTSD and polysubstance use.
How similar studies have performed: Previous research has shown promise in adapting PTSD interventions for various populations, but this specific adaptation for polysubstance users is relatively novel.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Bunting, Amanda M — New York University School of Medicine
- Study coordinator: Bunting, Amanda M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.